Menu
Back to Journals » OncoTargets and Therapy » Volume 6 » default
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6405)
- Volume 16, 2023 (114)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 6, 2013
A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients
Suenaga M, Yamada S, Fujii T, Fuchs BC, Okumura N, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Takeda S, Hayashi K, Tanabe KK, Goto H, Kodera Y
OncoTargets and Therapy 2013, 6:1805-1812
Published Date: 13 December 2013
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Fan Y, Huang Z, Fang L, Miu L, Lin N, Gong L, Yu H, Yang H, Mao W
OncoTargets and Therapy 2013, 6:1789-1803
Published Date: 4 December 2013
Optical imaging of head and neck squamous cell carcinoma in vivo using arginine-glycine- aspartic acid peptide conjugated near-infrared quantum dots
Huang H, Bai YL, Yang K, Tang H, Wang YW
OncoTargets and Therapy 2013, 6:1779-1787
Published Date: 2 December 2013
Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials
Zhang Y, Sun Y, Wang L, Ye T, Pan Y, Hu H, Yu Y, Zhao N, Song Y, Garfield D, Chen H
OncoTargets and Therapy 2013, 6:1771-1777
Published Date: 29 November 2013
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation
Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S
OncoTargets and Therapy 2013, 6:1761-1769
Published Date: 29 November 2013
Sam68 is a novel marker for aggressive neuroblastoma
Zhao X, Li Z, He B, Liu J, Li S, Zhou L, Pan C, Yu Z, Xu Z
OncoTargets and Therapy 2013, 6:1751-1760
Published Date: 2 December 2013
Signal transduction molecule patterns indicating potential glioblastoma therapy approaches
Cruceru ML, Enciu AM, Popa AC, Albulescu R, Neagu M, Tanase CP, Constantinescu SN
OncoTargets and Therapy 2013, 6:1737-1749
Published Date: 29 November 2013
The potential for targeting extracellular LOX proteins in human malignancy
Mayorca-Guiliani A, Erler JT
OncoTargets and Therapy 2013, 6:1729-1735
Published Date: 25 November 2013
Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
Tan W, Li Y, Han G, Xu J, Wang X, Li Y, Hu D
OncoTargets and Therapy 2013, 6:1719-1728
Published Date: 21 November 2013
Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis
Jin G, Zhao J, Qi H, Lou M, Liu X, Qu Y, Zhao L, Zhang W, Shao J, Zhong H
OncoTargets and Therapy 2013, 6:1707-1717
Published Date: 25 November 2013
Body mass index and patient CT measurements as a predictor of benefit of intensity-modulated radiotherapy to the supraclavicular fossa
Koh V, Tang JI, Choo BA, Tan CW, Lim BK, Shen L, Lu JJ
OncoTargets and Therapy 2013, 6:1701-1706
Published Date: 21 November 2013
Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective study
Gao Y, Liu Z, Gao F, Chen X
OncoTargets and Therapy 2013, 6:1695-1700
Published Date: 20 November 2013
Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T
OncoTargets and Therapy 2013, 6:1685-1693
Published Date: 18 November 2013
Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis
Cheng Q, Yi B, Wang A, Jiang X
OncoTargets and Therapy 2013, 6:1675-1684
Published Date: 18 November 2013
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
Qin XJ, Zhang HL, Ye DW, Dai B, Zhu Y, Shi GH
OncoTargets and Therapy 2013, 6:1667-1673
Published Date: 15 November 2013
Prognostic factors associated with solitary plasmacytoma
Guo SQ, Zhang L, Wang YF, Sun BC, Zhang LY, Zhang J, Wang GW, Zhang YZ
OncoTargets and Therapy 2013, 6:1659-1666
Published Date: 14 November 2013
Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity
Gadiot J, Hooijkaas AI, Deken MA, Blank CU
OncoTargets and Therapy 2013, 6:1649-1658
Published Date: 28 November 2013
The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells
Chai F, Zhou J, Chen C, Xie S, Chen X, Su P, Shi J
OncoTargets and Therapy 2013, 6:1643-1647
Published Date: 12 November 2013
Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer
Kim JS, Lee SD, Lee SJ, Chung MK
OncoTargets and Therapy 2013, 6:1635-1642
Published Date: 12 November 2013
Pulmonary adenocarcinoma with osseous metaplasia: a rare occurrence possibly associated with early stage?
Zhang Q, Yin L, Li B, Meng R, Dao R, Hu S, Qiu X
OncoTargets and Therapy 2013, 6:1631-1634
Published Date: 11 November 2013
Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma
Peng HH, Zhang YD, Gong LS, Liu WD, Zhang Y
OncoTargets and Therapy 2013, 6:1625-1630
Published Date: 11 November 2013
Profile of panobinostat and its potential for treatment in solid tumors: an update
Anne M, Sammartino D, Barginear MF, Budman D
OncoTargets and Therapy 2013, 6:1613-1624
Published Date: 15 November 2013
Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma
Feng JF, Huang Y, Liu JS
OncoTargets and Therapy 2013, 6:1605-1612
Published Date: 7 November 2013
Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
Shimada Y, Saji H, Nomura M, Matsubayashi J, Yoshida K, Kakihana M, Kajiwara N, Ohira T, Ikeda N
OncoTargets and Therapy 2013, 6:1597-1604
Published Date: 8 November 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial
Liang J, E M, Wu G, Zhao L, Li X, Xiu X, Li N, Chen B, Hui Z, Lv J, Fang H, Tang Y, Bi N, Wang W, Zhai Y, Li T, Chen D, Zou SM, Lu N, Perez-Rodríguez R, Zheng J, Wang L
OncoTargets and Therapy 2013, 6:1589-1596
Published Date: 6 November 2013
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
Mai CW, Kang YB, Pichika MR
OncoTargets and Therapy 2013, 6:1573-1587
Published Date: 5 November 2013
Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells
Fang ZT, Wang GZ, Zhang W, Qu XD, Liu R, Qian S, Zhu L, Zhou B, Wang JH
OncoTargets and Therapy 2013, 6:1563-1572
Published Date: 5 November 2013
Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature
Lin Y, Li Q, Huang W, Jia X, Jiang H, Gao Y, Li Q
OncoTargets and Therapy 2013, 6:1559-1562
Published Date: 5 November 2013
Diagnostic efficacy of computed tomography-guided transthoracic needle aspiration and biopsy in patients with pulmonary disease
Tuna T, Ozkaya S, Dirican A, Findik S, Atici AG, Erkan L
OncoTargets and Therapy 2013, 6:1553-1557
Published Date: 5 November 2013
New and emerging treatment options for biliary tract cancer
Noel MS, Hezel AF
OncoTargets and Therapy 2013, 6:1545-1552
Published Date: 30 October 2013
Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients
He L, Peng K, Liu Y, Xiong J, Zhu FF
OncoTargets and Therapy 2013, 6:1539-1543
Published Date: 30 October 2013
Focus on treatment of lung carcinoid tumor
Noel-Savina E, Descourt R
OncoTargets and Therapy 2013, 6:1533-1537
Published Date: 25 October 2013
Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma
Yuan Z, Tian L, Wang P, Song Y, Dong Y, Zhuang H
OncoTargets and Therapy 2013, 6:1527-1532
Published Date: 29 October 2013
Isolated epithelioid trophoblastic tumor of the vagina: a case report and review of the literature
Zhao J, Xiang Y, Zhao D, Ren T, Feng F, Wan X
OncoTargets and Therapy 2013, 6:1523-1526
Published Date: 29 October 2013
Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum ß-hCG: a case report and literature review
Ji M, Lu Y, Guo L, Feng F, Wan X, Xiang Y
OncoTargets and Therapy 2013, 6:1515-1522
Published Date: 24 October 2013
Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Chen D, Cheng J, Yang K, Ma Y, Yang F
OncoTargets and Therapy 2013, 6:1507-1514
Published Date: 24 October 2013
Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance
Sha JJ, Bo JJ, Pan JH, Zhang LH, Xuan HQ, Chen W, Li D, Wang ZL, Liu DM, Huang YR
OncoTargets and Therapy 2013, 6:1501-1506
Published Date: 24 October 2013
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
Zarogoulidis K, Boutsikou E, Zarogoulidis P, Darwiche K, Freitag L, Porpodis K, Latsios D, Kontakiotis T, Huang H, Li Q, Hohenforst-Schmidt W, Kipourou M, Turner JF, Spyratos D
OncoTargets and Therapy 2013, 6:1493-1500
Published Date: 22 October 2013
Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC
Wu X, Liang WH, Hou X, Lin Z, Zhao HY, Huang Y, Fang WF, Zhao YY, Wu JX, Yang YP, Xue C, Hu ZH, Zhang J, Zhang JW, Ma YX, Zhou T, Qin T, Zhang L
OncoTargets and Therapy 2013, 6:1481-1491
Published Date: 21 October 2013
Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking
Tan Q, Wang G, Huang J, Ding ZP, Luo QQ, Mok T, Tao Q, Lu S
OncoTargets and Therapy 2013, 6:1471-1479
Published Date: 21 October 2013
Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model
Kim DY, Song KJ, Kim SU, Yoo EJ, Park JY, Ahn SH, Han KH
OncoTargets and Therapy 2013, 6:1463-1469
Published Date: 16 October 2013
Survivin – biology and potential as a therapeutic target in oncology
Cheung CHA, Huang CC, Tsai FY, Lee JYC, Cheng SM, Chang YC, Huang YC, Chen SH, Chang JY
OncoTargets and Therapy 2013, 6:1453-1462
Published Date: 16 October 2013
VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
Fushida S, Oyama K, Kinoshita J, Yagi Y, Okamoto K, Tajima H, Ninomiya I, Fujimura T, Ohta T
OncoTargets and Therapy 2013, 6:1445-1451
Published Date: 16 October 2013
Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer
Wang Z, Wang Z, Liang Z, Liu J, Shi W, Bai P, Lin X, Magaye R, Zhao J
OncoTargets and Therapy 2013, 6:1437-1444
Published Date: 16 October 2013
Targeting hedgehog signaling in cancer: research and clinical developments
Xie J, Bartels CM, Barton SW, Gu D
OncoTargets and Therapy 2013, 6:1425-1435
Published Date: 10 October 2013
Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis
Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, Takeda S, Fujiwara M, Koike M, Sugimoto H, Fujii T, Nakayama G, Yamada S, Tanaka C, Kobayashi D, Kodera Y
OncoTargets and Therapy 2013, 6:1417-1424
Published Date: 9 October 2013
The emerging and diverse roles of sirtuins in cancer: a clinical perspective
Yuan H, Su L, Chen WY
OncoTargets and Therapy 2013, 6:1399-1416
Published Date: 8 October 2013
Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer
Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K
OncoTargets and Therapy 2013, 6:1393-1398
Published Date: 7 October 2013
Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy
Xu XX, Yan B, Wang ZX, Yu Y, Wu XX, Zhang YZ
OncoTargets and Therapy 2013, 6:1385-1392
Published Date: 8 October 2013
AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines
Leal P, Garcia P, Sandoval A, Buchegger K, Weber H, Tapia O, Roa JC
OncoTargets and Therapy 2013, 6:1373-1384
Published Date: 3 October 2013
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
Thon N, Kreth S, Kreth FW
OncoTargets and Therapy 2013, 6:1363-1372
Published Date: 27 September 2013
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A
OncoTargets and Therapy 2013, 6:1347-1361
Published Date: 30 September 2013
The relationship between Lin28 and the chemotherapy response of gastric cancer
Teng RY, Zhou JC, Jiang ZN, Xu CY, Li ZD, Wang QC, Xu CP, Guo JF, Shen JG, Wang LB
OncoTargets and Therapy 2013, 6:1341-1345
Published Date: 24 September 2013
Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment
Bavykin AS, Korotaeva AA, Poyarkov SV, Syrtsev AV, Tjulandin SA, Karpukhin AV
OncoTargets and Therapy 2013, 6:1333-1340
Published Date: 23 September 2013
Estimation of the displacement of cardiac substructures and the motion of the coronary arteries using electrocardiographic gating
Tan W, Xu L, Wang X, Qiu D, Han G, Hu D
OncoTargets and Therapy 2013, 6:1325-1332
Published Date: 20 September 2013
Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer
Sun W, Ai T, Gao Y, Zhang Y, Cui J, Song L
OncoTargets and Therapy 2013, 6:1315-1323
Published Date: 18 September 2013
Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients
Tejerizo-García A, Jiménez-López JS, Muñoz-González JL, Bartolomé-Sotillos S, Marqueta-Marqués L, López-González G, Pérez-Regadera Gómez JF
OncoTargets and Therapy 2013, 6:1305-1313
Published Date: 16 September 2013
IAP proteins as targets for drug development in oncology
Dubrez L, Berthelet J, Glorian V
OncoTargets and Therapy 2013, 6:1285-1304
Published Date: 16 September 2013
Impact of age on functional exercise correlates in patients with advanced lung cancer
Wang LY, Wu HD, Chen KY, Hsieh CH, Lai CC
OncoTargets and Therapy 2013, 6:1277-1283
Published Date: 16 September 2013
Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat
Voellger B, Kirches E, Wilisch-Neumann A, Weise A, Tapia-Perez JH, Rupa R, Mawrin C, Firsching R
OncoTargets and Therapy 2013, 6:1269-1276
Published Date: 16 September 2013
Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells
Castellanos JA, Merchant NB, Nagathihalli NS
OncoTargets and Therapy 2013, 6:1261-1267
Published Date: 13 September 2013
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
Espinoza I, Pochampally R, Xing F, Watabe K, Miele L
OncoTargets and Therapy 2013, 6:1249-1259
Published Date: 6 September 2013
How to detour Treg cells in T cell-based antitumor immune therapy
Zheng S, Shen Y, Song Y, Yuan Y
OncoTargets and Therapy 2013, 6:1243-1247
Published Date: 6 September 2013
The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer
Denaro N, Lo Nigro C, Russi EG, Merlano MC
OncoTargets and Therapy 2013, 6:1231-1241
Published Date: 16 September 2013
Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence
Mowla SN, Perkins ND, Jat PS
OncoTargets and Therapy 2013, 6:1221-1229
Published Date: 4 September 2013
Targeting cancer stem cells: emerging role of Nanog transcription factor
Wang ML, Chiou SH, Wu CW
OncoTargets and Therapy 2013, 6:1207-1220
Published Date: 4 September 2013
Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
Shaw HM, Hall M
OncoTargets and Therapy 2013, 6:1197-1206
Published Date: 3 September 2013
Lumbar paravertebral blockade as intractable pain management method in palliative care
Zaporowska-Stachowiak I, Kotlinska-Lemieszek A, Kowalski G, Kosicka K, Hoffmann K, Główka F, Łuczak J
OncoTargets and Therapy 2013, 6:1187-1196
Published Date: 3 September 2013
Clinical outcome of primary small cell carcinoma of the urinary bladder
Hou CP, Lin YH, Chen CL, Chang PL, Tsui KH
OncoTargets and Therapy 2013, 6:1179-1185
Published Date: 26 August 2013
Role of microRNAs in hepatocellular carcinoma: a clinical perspective
Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M
OncoTargets and Therapy 2013, 6:1167-1178
Published Date: 2 September 2013
Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer
Roh J, Sung YH, Lee HW
OncoTargets and Therapy 2013, 6:1161-1166
Published Date: 26 August 2013
MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia
Dou L, Li J, Zheng D, Li Y, Gao X, Xu C, Gao L, Wang L, Yu L
OncoTargets and Therapy 2013, 6:1153-1160
Published Date: 26 August 2013
Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus
Feng JF, Zhao HG, Liu JS, Chen QX
OncoTargets and Therapy 2013, 6:1147-1151
Published Date: 22 August 2013
Combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma
Yang R, Xu Y, Li P, Zhang X, Wang J, Gu D, Wang Y
OncoTargets and Therapy 2013, 6:1139-1146
Published Date: 20 August 2013
Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli
Han JB, Sang F, Chang JJ, Hua YQ, Shi WD, Tang LH, Liu LM
OncoTargets and Therapy 2013, 6:1129-1138
Published Date: 19 August 2013
Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells
Heinrich B, Goepfert K, Delic M, Galle PR, Moehler M
OncoTargets and Therapy 2013, 6:1119-1127
Published Date: 20 August 2013
Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia
Price KE, Saleem N, Lee G, Steinberg M
OncoTargets and Therapy 2013, 6:1111-1118
Published Date: 20 August 2013
Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
Solanki AA, Chang DT, Liauw SL
OncoTargets and Therapy 2013, 6:1097-1110
Published Date: 14 August 2013
Combining molecular targeted agents with radiation therapy for malignant gliomas
Scaringi C, Enrici RM, Minniti G
OncoTargets and Therapy 2013, 6:1079-1095
Published Date: 9 August 2013
Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens
Kader YA, El-Nahas T, Sakr A
OncoTargets and Therapy 2013, 6:1073-1077
Published Date: 9 August 2013
Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas
Kato R, Hasegawa K, Ishii R, Owaki A, Torii Y, Oe S, Hirasawa H, Kobayashi Y, Udagawa Y
OncoTargets and Therapy 2013, 6:1065-1071
Published Date: 7 August 2013
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples
Altimari A, de Biase D, De Maglio G, Gruppioni E, Capizzi E, Degiovanni A, D'Errico A, Pession A, Pizzolitto S, Fiorentino M, Tallini G
OncoTargets and Therapy 2013, 6:1057-1064
Published Date: 5 August 2013
Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1–6 cells
Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau HI, Chang FY, Tsai HH
OncoTargets and Therapy 2013, 6:1047-1055
Published Date: 5 August 2013
Single nucleotide polymorphisms in the mitochondrial displacement loop and age at onset of non-Hodgkin lymphoma
Fan H, Wang C, Guo Z
OncoTargets and Therapy 2013, 6:1041-1045
Published Date: 2 August 2013
Update on oncolytic viral therapy – targeting angiogenesis
Tysome JR, Lemoine NR, Wang Y
OncoTargets and Therapy 2013, 6:1031-1040
Published Date: 31 July 2013
Effect of transarterial chemoembolization with miriplatin plus epirubicin on local control of hepatocellular carcinoma: a retrospective comparison with miriplatin monotherapy
Hashimoto N, Iwazawa J, Ohue S, Mitani T
OncoTargets and Therapy 2013, 6:1025-1030
Published Date: 1 August 2013
Update on imatinib for gastrointestinal stromal tumors: duration of treatment
Linch M, Claus J, Benson C
OncoTargets and Therapy 2013, 6:1011-1023
Published Date: 30 July 2013
Critical analysis of the potential for targeting STAT3 in human malignancy
Peyser ND, Grandis JR
OncoTargets and Therapy 2013, 6:999-1010
Published Date: 30 July 2013
Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells
Chen YH, Wang JY, Pan BS, Mu YF, Lai MS, So EC, Wong TS, Huang BM
OncoTargets and Therapy 2013, 6:983-998
Published Date: 25 July 2013
The role of fluorescence diagnosis in clinical practice
Sieroń A, Sieroń-Stołtny K, Kawczyk-Krupka A, Latos W, Kwiatek S, Straszak D, Bugaj AM
OncoTargets and Therapy 2013, 6:977-982
Published Date: 24 July 2013
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
Rokita M, Stec R, Bodnar L, Charkiewicz R, Korniluk J, Smoter M, Cichowicz M, Chyczewski L, Nikliński J, Kozłowski W, Szczylik C
OncoTargets and Therapy 2013, 6:967-976
Published Date: 24 July 2013
Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis
Yang Z, Wei C, Luo Z, Li L
OncoTargets and Therapy 2013, 6:957-966
Published Date: 23 July 2013
Gamma secretase inhibitors of Notch signaling
Olsauskas-Kuprys R, Zlobin A, Osipo C
OncoTargets and Therapy 2013, 6:943-955
Published Date: 23 July 2013
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
Diaz-Miqueli A, Saurez Martinez G
OncoTargets and Therapy 2013, 6:931-942
Published Date: 24 July 2013
Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer
Xu R, Ma N, Wang F, Ma L, Chen R, Chen R, Kebinu M, Ma LL, Han ZC, Ayixiamu, Mayier M, Su PC, Naman YM, Jieensi H, Yang HX, Adili A, Aili S, Liu J
OncoTargets and Therapy 2013, 6:925-929
Published Date: 25 July 2013
Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer
Zhang Y, Hu J, Li J, Wang N, Li W, Zhou Y, Liu J, Wei L, Shi M, Wang S, Wang J, Li X, Ma W
OncoTargets and Therapy 2013, 6:917-923
Published Date: 19 July 2013
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective
Montanaro L, Treré D, Derenzini M
OncoTargets and Therapy 2013, 6:909-916
Published Date: 19 July 2013
Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX
Takatori E, Shoji T, Sawai T, Kurose A, Sugiyama T
OncoTargets and Therapy 2013, 6:901-907
Published Date: 17 July 2013
Current status of bevacizumab in advanced ovarian cancer
Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S
OncoTargets and Therapy 2013, 6:889-899
Published Date: 22 July 2013
Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
Luo RZ, Yuan ZY, Li M, Xi SY, Fu J, He J
OncoTargets and Therapy 2013, 6:883-888
Published Date: 19 July 2013
A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer
Ding C, Li C, Wang H, Li B, Guo Z
OncoTargets and Therapy 2013, 6:877-881
Published Date: 11 July 2013
Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors
Li ZY, Zhang XH, Chen Y, Guo JG, Sai K, Yang QY, Chen ZP, Mou YG
OncoTargets and Therapy 2013, 6:869-875
Published Date: 10 July 2013
Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer
Huang Y, He Y, Ye S, Li X, Zhong Q, Chen Z, Jin X
OncoTargets and Therapy 2013, 6:861-867
Published Date: 10 July 2013
Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract
Nagashima Y, Maeda N, Yamamoto S, Yoshino S, Oka M
OncoTargets and Therapy 2013, 6:853-859
Published Date: 9 July 2013
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer
Maric G, Rose AA, Annis MG, Siegel PM
OncoTargets and Therapy 2013, 6:839-852
Published Date: 9 July 2013
MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma
Tang M, Lin L, Cai H, Tang J, Zhou Z
OncoTargets and Therapy 2013, 6:833-838
Published Date: 8 July 2013
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology
González-Masiá JA, García-Olmo D, García-Olmo DC
OncoTargets and Therapy 2013, 6:819-832
Published Date: 8 July 2013
Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment
Zhao H, Zhao Y, Guo Y, Huang Y, Lin S, Xue C, Xu F, Zhang Y, Zhao L, Hu Z, Zhang L
OncoTargets and Therapy 2013, 6:811-818
Published Date: 3 July 2013
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation
Abdel Kader Y, Le Chevalier T, El-Nahas T, Sakr A
OncoTargets and Therapy 2013, 6:803-809
Published Date: 1 July 2013
Long term results of sentinel lymph node biopsy in early oral squamous cell carcinoma
Dequanter D, Shahla M, Paulus P, Lothaire P
OncoTargets and Therapy 2013, 6:799-802
Published Date: 25 June 2013
Potential use of custirsen to treat prostate cancer
Higano CS
OncoTargets and Therapy 2013, 6:785-797
Published Date: 25 June 2013
Apoptosis and G2/M arrest induced by Allium ursinum (ramson) watery extract in an AGS gastric cancer cell line
Xu XY, Song GQ, Yu YQ, Ma HY, Ma L, Jin YN
OncoTargets and Therapy 2013, 6:779-783
Published Date: 25 June 2013
Drugs for solid cancer the productivity crisis prompts a rethink
Rosel D, Brabek J, Vesely P, Fernandes M
OncoTargets and Therapy 2013, 6:767-777
Published Date: 26 June 2013
Efficacy of intraarterial chemoinfusion therapy for locally advanced breast cancer patients: a retrospective analysis of 28 cases
Zhang W, Liu R, Wang YY, Qian S, Wang JH, Yan ZP, Zhang HW
OncoTargets and Therapy 2013, 6:761-765
Published Date: 25 June 2013
Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
Yoo EJ, Shin HS, Kim SU, Joo DJ, Park JY, Choi GH, Kim DY, Ahn SH, Seong J, Koh MJ, Han KH, Chon CY
OncoTargets and Therapy 2013, 6:755-759
Published Date: 21 June 2013
Malignant thrombosis of the superior vena cava caused by non-small-cell lung cancer treated with radiation and erlotinib: a case with complete and prolonged response over 3 years
Wang JY, Liang J, Wang WQ, Ouyang H, Wang LH
OncoTargets and Therapy 2013, 6:749-753
Published Date: 1 July 2013
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia
Cross M, Bach E, Tran T, Krahl R, Jaekel N, Niederwieser D, Junghanss C, Maschmeyer G, Al-Ali HK
OncoTargets and Therapy 2013, 6:741-748
Published Date: 20 June 2013
Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors
Zhang Z, Hao C, Wang L, Liu P, Zhao L, Zhu C, Tian X
OncoTargets and Therapy 2013, 6:733-740
Published Date: 18 June 2013
Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients
Liu J, Shi L, Sartor O, Culbertson R
OncoTargets and Therapy 2013, 6:725-732
Published Date: 17 June 2013
Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma
Sonaglio V, de Carvalho AC, Toledo SRC, Salinas-Souza C, Carvalho AL, Petrilli AS, de Camargo B, Vettore AL
OncoTargets and Therapy 2013, 6:713-723
Published Date: 17 June 2013
Primary primitive neuroectodermal tumor of the cervix
Li B, Ouyang L, Han X, Zhou Y, Tong X, Zhang S, Zhang Q
OncoTargets and Therapy 2013, 6:707-711
Published Date: 17 June 2013
Fatal bleeding in a nasopharyngeal carcinoma patient after concurrent chemoradiation plus cetuximab: a case report
Zheng LY, Yan SX, Yan DF, Yang JS, Wang YX
OncoTargets and Therapy 2013, 6:703-706
Published Date: 13 June 2013
Human epidermal growth factor receptor 2-positive breast cancer: which cytotoxic agent best complements trastuzumab's efficacy in vitro?
Hurrell T, Outhoff K
OncoTargets and Therapy 2013, 6:693-701
Published Date: 17 June 2013
Preliminary study of CT in combination with MRI perfusion imaging to assess hemodynamic changes during angiogenesis in a rabbit model of lung cancer
Zhang Q, Shi B, Liu Z, Zhang M, Zhang W
OncoTargets and Therapy 2013, 6:685-692
Published Date: 17 June 2013
Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors
Cho DC
OncoTargets and Therapy 2013, 6:679-684
Published Date: 13 June 2013
Cyclin D1 affects epithelial–mesenchymal transition in epithelial ovarian cancer stem cell-like cells
Jiao J, Huang L, Ye F, Shi MF, Cheng XD, Wang XY, Hu DX, Xie X, Lu WG
OncoTargets and Therapy 2013, 6:667-677
Published Date: 20 June 2013
Current treatment options for management of anal intraepithelial neoplasia
Weis SE
OncoTargets and Therapy 2013, 6:651-665
Published Date: 10 June 2013
Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer
Chen ZW, Luo QQ, Jian H, Zhou Z, Cheng BJ, Lu S, Liao ML
OncoTargets and Therapy 2013, 6:645-650
Published Date: 7 June 2013
Current management options for recurrent adrenocortical carcinoma
Glover AR, Ip JCY, Zhao JT, Soon PSH, Robinson BG, Sidhu SB
OncoTargets and Therapy 2013, 6:635-643
Published Date: 6 June 2013
Nanomaterials in the application of tumor vaccines: advantages and disadvantages
Li XD, Gao JY, Yang Y, Fang HY, Han YJ, Wang XM, Ge W
OncoTargets and Therapy 2013, 6:629-634
Published Date: 5 June 2013
Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma
Özün Özbay P, Ekinci T, Yiğit S, Yavuzcan A, Uysal S, Soylu F, Cakalogaoglu F
OncoTargets and Therapy 2013, 6:621-627
Published Date: 7 June 2013
Increased CD70 expression is associated with clinical resistance to cisplatin-based chemotherapy and poor survival in advanced ovarian carcinomas
Liu N, Sheng X, Liu Y, Zhang X, Yu J
OncoTargets and Therapy 2013, 6:615-619
Published Date: 5 June 2013
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutspoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K
OncoTargets and Therapy 2013, 6:609-613
Published Date: 31 May 2013
The different radiosensitivity when combining erlotinib with radiation at different administration schedules might be related to activity variations in c-MET-PI3K-AKT signal transduction
Zhuang HQ, Bo QF, Yuan ZY, Wang J, Zhao LJ, Wang P
OncoTargets and Therapy 2013, 6:603-608
Published Date: 28 May 2013
Telangiectatic osteosarcoma: a review of literature
Liu J, Liu S, Wang J, Zhu W, Hua Y, Sun W, Cai Z
OncoTargets and Therapy 2013, 6:593-602
Published Date: 28 May 2013
Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
Shi Y, Qin R, Wang ZK, Dai GH
OncoTargets and Therapy 2013, 6:585-591
Published Date: 27 May 2013
Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
Luo J, Chen M, Huang H, Yan T, Zhang M, Zhang K, Deng S
OncoTargets and Therapy 2013, 6:577-583
Published Date: 22 May 2013
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
Berardi R, Santoni M, Morgese F, Ballatore Z, Savini A, Onofri A, Mazzanti P, Pistelli M, Pierantoni C, De Lisa M, Caramanti M, Pagliaretta S, Pellei C, Cascinu S
OncoTargets and Therapy 2013, 6:563-576
Published Date: 21 May 2013
Abundance of Flt3 and its ligand in astrocytic tumors
Eßbach C, Andrae N, Pachow D, Warnke JP, Wilisch-Neumann A, Kirches E, Mawrin C
OncoTargets and Therapy 2013, 6:555-561
Published Date: 24 May 2013
Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation
Zhuang XB, Qiao TK, Yuan SJ, Chen W, Zha L, Yan L
OncoTargets and Therapy 2013, 6:549-554
Published Date: 20 May 2013
New dilemmas in small-cell lung cancer TNM clinical staging
Zarogoulidis K, Latsios D, Porpodis K, Zarogoulidis P, Darwiche K, Antoniou N, Hohenforst-Schmidt W, Eleftheriadou E, Boutsikou E, Kontakiotis T
OncoTargets and Therapy 2013, 6:539-547
Published Date: 16 May 2013
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma
Terpos E, Kanellias N, Christoulas D, Kastritis E, Dimopoulos MA
OncoTargets and Therapy 2013, 6:531-538
Published Date: 10 May 2013
Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer
Chen XH, Li ZQ, Peng H, Jin SM, Fu HQ, Zhu TC, Weng XG
OncoTargets and Therapy 2013, 6:527-530
Published Date: 14 May 2013
Interleukin-12 prevents colorectal cancer liver metastases in mice
Shen F, Li JL, Cai WS, Zhu GH, Gu WL, Jia L, Xu B
OncoTargets and Therapy 2013, 6:523-526
Published Date: 13 May 2013
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
Yu L, Jing Y, Ma S, Li F, Zhang YF
OncoTargets and Therapy 2013, 6:517-521
Published Date: 10 May 2013
Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitro
Zhang ZM, Yang XM, Zhang C, Zhang MJ, Li X, Zhang FH, Kang S, Wang SJ, Shan BE
OncoTargets and Therapy 2013, 6:503-515
Published Date: 6 May 2013
PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
Zhang L, Shi L, Zhao X, Wang Y, Yue W
OncoTargets and Therapy 2013, 6:497-502
Published Date: 7 May 2013
Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial
Ueda A, Hosokawa A, Ogawa K, Yoshita H, Ando T, Kajiura S, Fujinami H, Kawai K, Nishikawa J, Tajiri K, Minemura M, Sugiyama T
OncoTargets and Therapy 2013, 6:491-496
Published Date: 8 May 2013
Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer
Wu Q, Shi Y, Chen L, Xiao XY, Dai GH
OncoTargets and Therapy 2013, 6:485-490
Published Date: 30 April 2013
A review of the use of somatostatin analogs in oncology
Keskin O, Yalcin S
OncoTargets and Therapy 2013, 6:471-483
Published Date: 26 April 2013
Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors
L'Heureux-Lebeau B, Saliba I
OncoTargets and Therapy 2013, 6:459-470
Published Date: 26 April 2013
Candidate cancer-targeting agents identified by expression-profiling arrays
Termglinchan V, Wanichnopparat W, Suwanwongse K, Teeyapant C, Chatpermporn K, Leerunyakul K, Chuadpia K, Sirimaneethum O, Wijitworawong P, Mutirangura W, Aporntewan C, Vinayanuwattikun C, Mutirangura A
OncoTargets and Therapy 2013, 6:447-458
Published Date: 23 April 2013
Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment
Rachmut IH, Samuels N, Melnick SJ, Ramachandran C, Sharabi Y, Pavlovsky A, Maimon Y, Shoham J
OncoTargets and Therapy 2013, 6:437-445
Published Date: 24 April 2013
Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma
Hirte HW
OncoTargets and Therapy 2013, 6:427-435
Published Date: 18 April 2013
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment
Tian DW, Sun Y, Yang Y, Lei MD, Ding N, Han RF
OncoTargets and Therapy 2013, 6:419-426
Published Date: 18 April 2013
RUNX3 gene promoter demethylation by 5-Aza-CdR induces apoptosis in breast cancer MCF-7 cell line
Kang HF, Dai ZJ, Bai HP, Lu WF, Ma XB, Bao X, Lin S, Wang XJ
OncoTargets and Therapy 2013, 6:411-417
Published Date: 17 April 2013
Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)
Amini A, Ehteda A, Masoumi Moghaddam S, Akhter J, Pillai K, Morris DL
OncoTargets and Therapy 2013, 6:403-409
Published Date: 16 April 2013
An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer
Rick FG, Block NL, Schally AV
OncoTargets and Therapy 2013, 6:391-402
Published Date: 16 April 2013
Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges
Rahmathulla G, Hovey EJ, Hashemi-Sadraei N, Ahluwalia MS
OncoTargets and Therapy 2013, 6:371-389
Published Date: 15 April 2013
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study
Huang L, Li GM, Zhu JY, Li Z, Li T, Leng XS
OncoTargets and Therapy 2013, 6:369-370
Published Date: 12 April 2013
Evaluation of the efficacy of a novel radical neck dissection preserving the external jugular vein, greater auricular nerve, and deep branches of the cervical nerve
Li Y, Zhang J, Yang K
OncoTargets and Therapy 2013, 6:361-367
Published Date: 10 April 2013
Laparoscopic partial nephrectomy of thyroid cancer metastasis: case report and review of the literature
Cochetti G, Puxeddu E, Del Zingaro M, D’Amico F, Cottini E, Barillaro F, Mearini E
OncoTargets and Therapy 2013, 6:355-360
Published Date: 10 April 2013
MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B
Yu XY, Zhang Z, Liu J, Zhan B, Kong CZ
OncoTargets and Therapy 2013, 6:349-354
Published Date: 10 April 2013
HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients
Qin T, Yuan Z, Peng R, Bai B, Shi Y, Teng X, Liu D, Wang S
OncoTargets and Therapy 2013, 6:341-347
Published Date: 9 April 2013
A brief review of different types of sweat-gland carcinomas in the eyelid and orbit
Zhang L, Ge S, Fan X
OncoTargets and Therapy 2013, 6:331-340
Published Date: 9 April 2013
A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging
Yokoyama J, Fujimaki M, Ohba S, Anzai A, Yoshii R, Ito S, Kojima M, Ikeda K
OncoTargets and Therapy 2013, 6:325-330
Published Date: 8 April 2013
Update of research on the role of EZH2 in cancer progression
Shen L, Cui J, Liang S, Pang Y, Liu P
OncoTargets and Therapy 2013, 6:321-324
Published Date: 4 April 2013
Primary malignant fibrous histiocytoma of the breast: report of one case
Liu C, Zhao Z, Zhang Q, Wu Y, Jin F
OncoTargets and Therapy 2013, 6:315-319
Published Date: 3 April 2013
Resting-state magnetoencephalography study of “small world” characteristics and cognitive dysfunction in patients with glioma
Hu X, Lei T, Xu HZ, Zou YJ, Liu HY
OncoTargets and Therapy 2013, 6:311-313
Published Date: 3 April 2013
Application of quantum dots as vectors in targeted survivin gene siRNA delivery
Zhao JJ, Qiu XL, Wang ZP, Pan J, Chen J, Han JS
OncoTargets and Therapy 2013, 6:303-309
Published Date: 3 April 2013
Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer
Gao Y, Gao F, Liu Z, Song LP
OncoTargets and Therapy 2013, 6:297-302
Published Date: 2 April 2013
Improving survival and preventing recurrence of diffuse large B-cell lymphoma in younger patients: current strategies and future directions
Karlin L, Coiffier B
OncoTargets and Therapy 2013, 6:289-296
Published Date: 31 March 2013
Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma
Wang Z, Zhang H, He L, Dong W, Li J, Shan Z, Teng W
OncoTargets and Therapy 2013, 6:281-287
Published Date: 28 March 2013
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer
Dong X, Yang M, Sun H, Lü J, Zheng Z, Li Z, Zhong L
OncoTargets and Therapy 2013, 6:273-279
Published Date: 28 March 2013
Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experience
Boselli C, Renzi C, Gemini A, Castellani E, Trastulli S, Desiderio J, Corsi A, Barberini F, Cirocchi R, Santoro A, Parisi A, Redler A, Noya G
OncoTargets and Therapy 2013, 6:267-272
Published Date: 27 March 2013
Systematic review of dasatinib in chronic myeloid leukemia
Breccia M, Salaroli A, Molica M, Alimena G
OncoTargets and Therapy 2013, 6:257-265
Published Date: 27 March 2013
Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential
Alexanian A, Sorokin A
OncoTargets and Therapy 2013, 6:243-255
Published Date: 26 March 2013
Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice
Araya T, Kasahara K, Nishikawa S, Kimura H, Sone T, Nagae H, Ikehata Y, Nagano I, Fujimura M
OncoTargets and Therapy 2013, 6:237-242
Published Date: 24 March 2013
Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature
Xu D, Bi T, Lan H, Yu W, Wang W, Cao F, Jin K
OncoTargets and Therapy 2013, 6:233-236
Published Date: 26 March 2013
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
Ho AS, Turcan S, Chan TA
OncoTargets and Therapy 2013, 6:223-232
Published Date: 21 March 2013
Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib
Rajendra R, Jones RL, Pollack SM
OncoTargets and Therapy 2013, 6:217-222
Published Date: 18 March 2013
Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma
Wang D, Yang JX, Cao DY, Wan XR, Feng FZ, Huang HF, Shen K, Xiang Y
OncoTargets and Therapy 2013, 6:211-216
Published Date: 16 March 2013
Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression
Gu X, Xu Z, Zhu LY, Wang L, Li K, Pei Q
OncoTargets and Therapy 2013, 6:199-209
Published Date: 22 March 2013
Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation
Duan Y, Zhao X, Ren W, Wang X, Yu KF, Li D, Zhang X, Zhang Q
OncoTargets and Therapy 2013, 6:189-198
Published Date: 14 March 2013
Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance
Zhao C, Chen Y, Zhang W, Zhang J, Xu Y, Li W, Chen S, Deng A
OncoTargets and Therapy 2013, 6:183-188
Published Date: 8 March 2013
3´ untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer
Tang L, Zhao Y, Nie W, Wang Z, Guan X
OncoTargets and Therapy 2013, 6:177-182
Published Date: 9 March 2013
Novel Bruton's tyrosine kinase inhibitors currently in development
D'Cruz OJ, Uckun FM
OncoTargets and Therapy 2013, 6:161-176
Published Date: 6 March 2013
Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
Yamane H, Ochi N, Yasugi M, Tabayashi T, Yamagishi T, Monobe Y, Hisamoto A, Kiura K, Takigawa N
OncoTargets and Therapy 2013, 6:155-160
Published Date: 6 March 2013
Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling
Jin H, Gong W, Zhang C, Wang S
OncoTargets and Therapy 2013, 6:145-153
Published Date: 8 March 2013
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC
Nelson V, Ziehr J, Agulnik M, Johnson M
OncoTargets and Therapy 2013, 6:135-143
Published Date: 5 March 2013
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
Boutsikou E, Kontakiotis T, Zarogoulidis P, Darwiche K, Eleptheriadou E, Porpodis K, Galaktidou G, Sakkas L, Hohenforst-Schmidt W, Tsakiridis K, Karaiskos T, Zarogoulidis K
OncoTargets and Therapy 2013, 6:125-134
Published Date: 1 March 2013
Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview
Zhu C, Jin K
OncoTargets and Therapy 2013, 6:119-124
Published Date: 3 March 2013
Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
Elit L, Hirte H
OncoTargets and Therapy 2013, 6:107-118
Published Date: 26 February 2013
Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia
Keller-von Amsberg G, Koschmieder S
OncoTargets and Therapy 2013, 6:99-106
Published Date: 4 March 2013
Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?
Gazzah A, Gonzales DB, Levy A, Bahleda R, Ducreux M, Lacroix L, Soria JC
OncoTargets and Therapy 2013, 6:95-97
Published Date: 20 February 2013
Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer
Hamizi S, Freyer G, Bakrin N, Henin E, Mohtaram A, Le Saux O, Falandry C
OncoTargets and Therapy 2013, 6:89-94
Published Date: 14 February 2013
The feasibility of a fiber optic laser approach to relieving lymphedematous syndrome: a case report
Palmieri B, Di Cerbo A, Rottigni V, Fistetto G, Iannitti T
OncoTargets and Therapy 2013, 6:85-88
Published Date: 11 February 2013
Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells
Alarifi S, Ali D, Alkahtani S, Siddiqui MA, Ali BA
OncoTargets and Therapy 2013, 6:75-84
Published Date: 7 February 2013
Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma
Wei LC, Wang N, Shi M, Liu JY, Li JP, Zhang Y, Huang YH, Li X, Chen Y
OncoTargets and Therapy 2013, 6:67-74
Published Date: 7 February 2013
Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients – a preliminary result
Hsieh CH, Tien HJ, Hsiao SM, Wei MC, Wu WY, Sun HD, Wang LY, Hsieh YP, Chen YJ, Shueng PW
OncoTargets and Therapy 2013, 6:59-66
Published Date: 4 February 2013
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
Geva R, Vecchione L, Tejpar S, Piessevaux H, Van Cutsem E, Prenen H
OncoTargets and Therapy 2013, 6:53-58
Published Date: 25 January 2013
Learning curve for endoscopic thyroidectomy: a single teaching hospital study
Cao F, Jin K, Cui B, Xie B
OncoTargets and Therapy 2013, 6:47-52
Published Date: 23 January 2013
Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model
Zhao NB, Tang H, Yang K, Chen D
OncoTargets and Therapy 2013, 6:41-46
Published Date: 23 January 2013
Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses
Andoh Y, Makino N, Yamakawa M
OncoTargets and Therapy 2013, 6:29-40
Published Date: 22 January 2013
Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report
Shen BJ, Lin SC, Shueng PW, Chou YH, Tseng LM, Hsieh CH
OncoTargets and Therapy 2013, 6:25-28
Published Date: 17 January 2013
Expression of novel tumor markers of pancreatic adenocarcinomas in intrahepatic cholangiocarcinomas
Zong M, Jia L, Li L
OncoTargets and Therapy 2013, 6:19-23
Published Date: 11 January 2013
Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions
Bedoya DJ, Mitsiades N
OncoTargets and Therapy 2013, 6:9-18
Published Date: 3 January 2013
Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer
Hart CD, De Boer RH
OncoTargets and Therapy 2013, 6:1-7
Published Date: 3 January 2013